Vasopressin Injection recall in Canada: product differences
In plain language
This notice involves US-authorized Vasopressin Injection, USP, 20 units/mL, imported into Canada. It's being imported due to a shortage of the Canadian-authorized product. There are important differences between the US and Canadian versions regarding use and administration. Healthcare professionals should be aware of these differences.
What to do
- Healthcare professionals should be aware of the differences between the US and Canadian products.
- Consult the US Prescribing Information for proper use of the US-authorized product.
- Note that the US-authorized product is for IV infusion only after dilution.
- Do not use the US-authorized product for IM or SC administration.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Vasopressin Injection, USP
UPC: NDC 63323-930-01
Model: Product Code: 930101
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the UPC code
The UPC is the barcode number on the packaging.
Affected UPCs: NDC 63323-930-01
- 3
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: Product Code: 930101
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This notice involves US-authorized Vasopressin Injection, USP, 20 units/mL, imported into Canada. It's being imported due to a shortage of the Canadian-authorized product. There are important differences between the US and Canadian versions regarding use and administration. Healthcare professionals should be aware of these differences.
What should consumers do?
Healthcare professionals should be aware of the differences between the US and Canadian products. Consult the US Prescribing Information for proper use of the US-authorized product. Note that the US-authorized product is for IV infusion only after dilution. Do not use the US-authorized product for IM or SC administration.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on March 4, 2026.
Is the Vasopressin Injection, USP brand affected by this recall?
Yes, Vasopressin Injection, USP products are affected by this recall. This notice involves US-authorized Vasopressin Injection, USP, 20 units/mL, imported into Canada. It's being imported due to a shortage of the Canadian-authorized product. There are important differences between the US and Canadian versions regarding use and administration. Healthcare professionals should be aware of these differences.